Patient Resources
Get Healthy!
Results for search "Drug Approvals".
Health News Results - 30
Experimental Alzheimer's Drug Slows Thinking Declines in Late-Stage Trial
- Robin Foster HealthDay Reporter
- July 17, 2023
- Full Page
Another experimental drug meant to slow the damage of Alzheimer's appears poised to join a growing arsenal of new treatments for this memory-robbing disease.
FDA Gives Full Approval to Alzheimer's Drug Leqembi
- Robin Foster HealthDay Reporter
- July 6, 2023
- Full Page
The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer's drug Leqembi, clearing the way for insurance coverage of the pricey drug.
“The full FDA approval will open the floodgates for people with early Alzheimer's to get this drug. It's a ...
FDA Approves New Drugs to Treat Type 2 Diabetes in Kids
- Cara Murez HealthDay Reporter
- June 21, 2023
- Full Page
The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up.
The approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) provid...
FDA Approves First Pill to Treat Moderate-to-Severe Crohn's Disease
- Cara Murez HealthDay Reporter
- May 19, 2023
- Full Page
Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).
Rinvoq is meant to treat adults with moderately to severely active Crohn's disease who have not had success with TNF (t...
FDA Approves First Drug Meant to Ease Alzheimer's-Linked Agitation
- Cara Murez HealthDay Reporter
- May 11, 2023
- Full Page
A medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.
The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti ...
Experimental Alzheimer's Drug Slows Decline in Thinking in Late-Stage Trial
- Cara Murez HealthDay Reporter
- May 3, 2023
- Full Page
Another experimental drug meant for Alzheimer's disease looks so promising that drugmaker Eli Lilly plans to ask the U.S. Food and Drug Administration for full approval by the end of June.
Known as donanemab, the medication clears amyloid plaque from the brain. In a lat...
Could a Vibrating Pill Ease Chronic Constipation?
- Cara Murez HealthDay Reporter
- February 9, 2023
- Full Page
A new treatment for chronic constipation may bring relief without having to use drugs.
It's a vibrating pill called Vibrant that stimulates the colon as it passes through the body.
FDA Approves New 2-Drug Combo Medicine for Asthma
- Cara Murez HealthDay Reporter
- January 12, 2023
- Full Page
Adults with asthma now have a new rescue medication to turn to after the U.S. Food and Drug Administration approved Airsupra on Wednesday.
The drug is the f...
First FDA-Approved Fecal-Based Treatment Helps Fight a Tough Superbug
- Cara Murez HealthDay Reporter
- December 1, 2022
- Full Page
The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections.
"Today's approval of Rebyota is an advance in caring f...
A Gene Therapy for Hemophilia That Costs $3.5 Million Gets FDA Approval
- Cara Murez HealthDay Reporter
- November 23, 2022
- Full Page
People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag.
The U.S. Food and Drug Administration approved the new gene therapy Hemgenix on Nov. 22. Soon after, drugmaker CSL Behring revealed its cost.
FDA Approves New ALS Drug Despite Uncertain Data
- Ernie Mundell HealthDay Reporter
- September 30, 2022
- Full Page
The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for
Hints That Experimental Drug Might Curb a Form of ALS
- By Cara Murez HealthDay Reporter
- September 23, 2022
- Full Page
People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows.
The medication, tofersen, benefited patients with mutations of the gene SOD1. These mutations create a misfolded version of a protein, which leads to
Merck's COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDA
- Robert Preidt and Robin Foster
- November 29, 2021
- Full Page
Merck's experimental COVID-19 antiviral pill appears effective, but may pose risks for pregnant women, including birth defects and toxicity to developing fetuses, according to the U.S. Food and Drug Administration.
FDA Panel Advisor Who Panned New Alzheimer's Drug Speaks Out
- Dennis Thompson HealthDay Reporter
- July 28, 2021
- Full Page
An outside advisor to the U.S. Food and Drug Administration's review of the controversial Alzheimer's drug Aduhelm is now speaking out, arguing that the approval was based on dodgy science and involved questionable collaboration between regulators and the drug's maker.
"...
Doctors Divided Over Use of Controversial New Alzheimer's Drug
- Dennis Thompson HealthDay Reporter
- July 23, 2021
- Full Page
The controversial new Alzheimer's drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication.
Many doctors believe t...
FDA Approves First Lymphoma Drug for Dogs
- Robert Preidt
- July 16, 2021
- Full Page
The first full approval of a drug to treat lymphoma in dogs has been granted by the U.S. Food and Drug Administration.
"While canine lymphoma affects fewer than 70,000 dogs in the U.S. annually, it accounts for up to 24% of all cancers in dogs, making it one of the most ...
FDA Defends Approval of Controversial Alzheimer's Drug
- Dennis Thompson HealthDay Reporter
- June 7, 2021
- Full Page
The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science.
Aduhelm (aducanumab) treats Alzheimer's by clearing out am...
'Historic' Decision Expected on U.S. Approval of Alzheimer's Drug
- Dennis Thompson HealthDay Reporter
- June 7, 2021
- Full Page
The first drug ever shown to slow the progression of Alzheimer's disease could be approved by the U.S. Food and Drug Administration on Monday, but experts say that approval will be surrounded by controversy.
In clinical trials, aducanumab showed a 22% reduction in the de...
Race Against Time: Stricken With ALS, She's Seeking Access to Experimental Drug
- Serena McNiff HealthDay Reporter
- April 28, 2021
- Full Page
Like many proud moms, Lisa Stockman-Mauriello of Summit, N.J., is looking forward to exciting milestones in lives of her three sons over the coming months: One will graduate college, one will enter college, and the third will begin high school.
But unlike other moms, it...
FDA Approves First Once-a-Month HIV Therapy
- Robert Preidt
- January 22, 2021
- Full Page
The first monthly shots to treat adults with HIV were approved by the U.S. Food and Drug Administration on Thursday.
"Currently, the standard of care for patients with HIV includes patients taking daily pills to adequately manage their condition. This approval will allow...
Immunotherapy Drug Boosts Survival for Lung Cancer Patients
- Robert Preidt
- October 1, 2020
- Full Page
A newly approved drug for the leading form of the number one cancer killer, lung cancer, does improve patient survival, a new study confirms.
The immunotherapy drug Tecentriq (atezolizumab) was approved earlier this year by the U.S. Food and Drug Administration to tr...
FDA OKs First Generic Version of Daraprim, Best Known as the 'Pharma Bro' Drug
- Robert Preidt
- March 2, 2020
- Full Page
The first generic version of Daraprim (pyrimethamine) tablets for the treatment of toxoplasmosis has been approved by the U.S. Food and Drug Administration.
"Today's approval is especially important for populations that are more susceptible to toxoplasmosis infection...
New Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?
- Dennis Thompson
- January 14, 2020
- Full Page
New drugs are being approved by the U.S. Food and Drug Administration for patients based on less and less solid evidence, thanks to incentive programs that have been created to promote drug development, a new study shows.
Researchers report that more than 8 out of 10...
FDA Gives First Ebola Vaccine for Adults the Green Light
- Robert Preidt
- December 20, 2019
- Full Page
The first Ebola vaccine approved by the U.S. Food and Drug Administration is a single-dose injection called Ervebo.
The vaccine from Merck & Co. is approved to protect against the Zaire ebolavirus in people 18 and older.
In the United States, Ebo...
FDA Approves First Generic Forms of MS Drug Gilenya
- Robert Preidt
- December 6, 2019
- Full Page
The first generic versions of the multiple sclerosis drug Gilenya have been approved by the U.S. Food and Drug Administration.
The three generic versions of Gilenya (fingolimod) capsules were approved for the treatment of relapsing forms of multiple sclerosis (MS) in...
FDA Approves Drug for Most Deadly Form of TB
- Robert Preidt
- August 15, 2019
- Full Page
A new drug has been approved as part of a powerful, three-pronged treatment regimen for the most deadly strain of tuberculosis, the U.S. Food and Drug Administration announced Wednesday.
Pretomanid tablets were approved to be used with bedaquiline and linezolid in a...
Second New MS Drug Secures FDA Approval
- Robert Preidt
- April 1, 2019
- Full Page
The U.S. Food and Drug Administration has approved another new multiple sclerosis drug -- the second in one week.
Mavenclad (cladribine) pills can be used to treat relapsing forms of MS in adults, including relapsing-remitting disease and active secondary progressive...
FDA OKs Blood Pressure Drug to Ease Shortage Due to Recalls
- Robert Preidt
- March 13, 2019
- Full Page
The U.S. Food and Drug Administration on Tuesday approved a new generic version of the high blood pressure/heart failure drug valsartan, saying the move might help ease the current medication shortage.
The agency said it prioritized review of the drug from Alkem Labo...
Why Do More and More Americans Use Medical Marijuana?
- Robert Preidt
- February 5, 2019
- Full Page
Easing chronic pain is the main reason Americans use medical marijuana, a new study finds.
"We wanted to understand the reasons why people are using cannabis medically, and whether those reasons for use are evidence-based," said lead author Kevin Boehnke. He's an inv...
Generic Version of Popular Asthma Inhaler Wins FDA Approval
- Robert Preidt
- January 31, 2019
- Full Page
The first generic version of the widely used Advair Diskus inhaler for asthma and chronic obstructive pulmonary disease (COPD) has won U.S. Food and Drug Administration approval.
This approval "is part of our longstanding commitment to advance access to lower cost, h...